Quantification of plasminogen activator inhibitor type 1 in the aortic wall

V Kríková1, M Korabecná, J Kocová

  • 1Department of Histology and Embryology, Charles University, Pilsen, Czech Republic. vera.krizkova@lfp.cuni.cz

Insights

Plasminogen activator inhibitor type 1 (PAI-1) expression decreases in abdominal aortic aneurysms (AAA) with disease progression. PAI-1 redistribution in cells correlates with AAA clinical classification.

Area of Science:

  • Vascular Biology
  • Biochemistry
  • Histopathology

Background:

  • Plasminogen activator inhibitor type 1 (PAI-1) is crucial for regulating the fibrinolytic system and smooth muscle cell (SMC) migration.
  • Understanding PAI-1 expression in abdominal aortic aneurysms (AAA) is vital for comprehending disease pathogenesis.
  • Abnormalities in fibrinolysis are implicated in the development and progression of AAA.

Purpose of the Study:

  • To identify PAI-1 expressing cells in AAA walls.
  • To quantify PAI-1 expression levels in different stages of AAA.
  • To correlate PAI-1 expression with histological and clinical findings in AAA patients.

Main Methods:

  • Histological and immunohistochemical analysis of aortic wall samples from nine AAA patients (asymptomatic, symptomatic, ruptured) and one control.
  • In situ hybridization was used for PAI-1 detection.
  • Quantification of PAI-1 area fraction and cell expression (endothelium, SMC, foam cells) using Ellipse software and analysis by two independent observers.

Main Results:

  • PAI-1 area fraction decreased from 28.6% in controls to 18.1% in asymptomatic AAA, 10.9% in symptomatic AAA, and 11.0% in ruptured AAA.
  • Smooth muscle cells (SMC) were the primary cells expressing PAI-1, and their abundance decreased as AAA progressed.
  • In ruptured AAA, PAI-1 was detected in the necrotic centers of atheromatous plaques.

Conclusions:

  • Abdominal aortic aneurysms (AAA) development involves gradual changes in fibrinolysis regulation, evidenced by PAI-1 cell redistribution.
  • The quantified area fraction of PAI-1 positive components shows a correlation with the clinical classification of AAA.
  • PAI-1 expression patterns offer insights into AAA pathogenesis and progression.
Abstract